NCT07084168Recruiting
Multimedia Aid for Genetic Testing in Gynecologic Oncology
Source: ClinicalTrials.gov · Last updated 12 Nov 2025
Brief summary (registry, in English)
This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted. Up to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 16 Jul 2025
- Start date
- Oct 2024
- Primary completion date
- Oct 2026
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Diseases
- Endometrial cancer, Ovarian cancer
- NCT number
- NCT07084168
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Oct 2024 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously completed genetic testing
Other illness
- Did not receive initial cancer-directed treatment at study site
Who the study is looking for
- In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.
- Reviewed informed consent to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator.
- Age ≥ 18 years at the time of consent.
- Diagnosis of ovarian cancer or endometrial cancer
- Eligible for genetic testing
- English or Spanish is the primary language
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Univeristy of North Carolina at Chapel Hill Coordinator of this site? Confirm its status | Chapel Hill | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.